今年，分别向 AppLovin、MicroStrategy 和 Summit Therapeutics 投资 5,000 美元，收益超过 100,000 美元。 Investing $5,000 each in AppLovin, MicroStrategy, and Summit Therapeutics yielded over $100,000 in gains this year.

2024年初,对三股股票——App Lovin、Micro战略以及首脑会议治疗学——各投资5 000美元,今天本可产生价值超过100 000美元的投资组合。 Investing $5,000 in each of three stocks—AppLovin, MicroStrategy, and Summit Therapeutics—at the start of 2024 could have resulted in a portfolio worth over $100,000 today. Applovin,一家软件公司,增加了750%。 AppLovin, a software company, saw a 750% increase. 由于有前景的药物正在开发, Summit Therapeutics 制药公司的市值很高,以及在比特币上大力投资的 MicroStrategy 公司均显示出显著的增长. Summit Therapeutics, a pharmaceutical company with a high market cap due to promising drugs in development, and MicroStrategy, which heavily invests in Bitcoin, both showed significant growth. 尽管取得了这些收益,但风险依然存在,包括股票估值高和暗通货币波动不定。 Despite the gains, risks remain, including high stock valuations and cryptocurrency volatility.